Klöcking et al., 2005 - Google Patents
Interaction of humic acids and humic-acid-like polymers with herpes simplex virus type 1Klöcking et al., 2005
- Document ID
- 17638398903397563460
- Author
- Klöcking R
- Helbig B
- Publication year
- Publication venue
- Humic Substances in the Aquatic and Terrestrial Environment: Proceedings of an International Symposium Linköping, Sweden, August 21–23, 1989
External Links
Snippet
The study was performed in order to compare the antiviral activity against herpes simplex virus type 1 (HSV-1) of synthetic humic-acid-like polymers to that of their low-molecular- weight basic compounds and naturally occurring humic acids (HA) in vitro. HA from peat …
- 239000004021 humic acid 0 title abstract description 31
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Marcocci et al. | The amphibian antimicrobial peptide temporin b inhibits in vitro herpes simplex virus 1 infection | |
| Milewska et al. | Novel polymeric inhibitors of HCoV-NL63 | |
| Wagner | Virus inactivation in blood components by photoactive phenothiazine dyes | |
| RU2124361C1 (en) | Method of isolation of resin tragacanth polysaccharide fraction from plant of genus astragal, composition based on polysaccharide fraction, method of inhibition of cancer tumor growth, method of inhibition of viral infections | |
| Pujol et al. | Antiviral activity of a carrageenan from Gigartina skottsbergii against intraperitoneal murine herpes simplex virus infection | |
| JP2001500471A (en) | Methods for improving the biological and antiviral activity of protease inhibitors | |
| Sidwell et al. | In vitro and in vivo Phlebovirus inhibition by ribavirin | |
| Rajbhandari et al. | Inhibitory effect of Bergenia ligulata on influenza virus A | |
| TURANO et al. | Inhibitory effect of papaverine on HIV replication in vitro | |
| Klöcking et al. | Interaction of humic acids and humic-acid-like polymers with herpes simplex virus type 1 | |
| Lu et al. | In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid | |
| Shefer et al. | Fighting SARS-CoV-2 with green seaweed Ulva sp. extract: extraction protocol predetermines crude ulvan extract anti-SARS-CoV-2 inhibition properties in in vitro Vero-E6 cells assay | |
| Zhao et al. | Chemically sulfated polysaccharides from Agaricus Blazei Murill: synthesis, characterization and anti‐HIV activity | |
| CN111135167A (en) | Application of GC376 in the preparation of novel coronavirus SARS-CoV-2 inhibitor | |
| US5223258A (en) | Antiviral disinfecting composition and method of inactivating the aids virus in vitro | |
| Lampidis et al. | Nuclear and mitochondrial effects of adriamycin in singly isolated pulsating myocardial cells | |
| RU2118163C1 (en) | Drug for treatment of patients with viral disease | |
| RU2499002C1 (en) | Conjugates of gossypol and sodium-carboxymethyl cellulose, their production methods and antiviral agents on their basis | |
| AU737861B2 (en) | Remedies for AIDS | |
| CN111212901A (en) | Blue-green algae extract and preparation method and use thereof | |
| Bogoch | Interaction of viruses with native brain substrates | |
| RU2394618C2 (en) | Water-soluble polymeric complexes of arbidol | |
| Salgado-Benvindo et al. | Honokiol inhibits SARS-CoV-2 replication in cell culture | |
| RU2444363C2 (en) | Antiviral agent for preventing and treating tick-borne encephalitis | |
| RU2283126C1 (en) | Agent for prophylaxis and treatment of viral avian influenza |